SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001176256-13-000426
Filing Date
2013-07-31
Accepted
2013-07-31 17:26:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10588
2 nymoxcorresp130731x1x1.jpg GRAPHIC 2645
  Complete submission text file 0001176256-13-000426.txt   15305
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances